For research and educational purposes only. Not medical advice.

Pramiracetam Reference

Educational, not medical advice reference for Pramiracetam: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Als…

Reference summary

Smaller Italian clinical literature; reportedly higher choline-system activity than other racetams.

Categories
Nootropic, Cognitive
Aliases
Pramistar, CI-879
Evidence posture
human — Not FDA-approved in the US. Italian non-US approval. Community framing extrapolates beyond the approved cognitive-impairment indication.
Regulatory status
No FDA-approved pramiracetam drug label. Approved in Italy for memory / cognitive impairment under the brand Pramistar.
Content review status
research reference

Selected public sources